Common Stock, Shares, Issued of MARIZYME, INC. from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
MARIZYME, INC. quarterly Common Stock, Shares, Issued history and change rate from Q4 2010 to Q3 2024.
  • MARIZYME, INC. Common Stock, Shares, Issued for the quarter ending 30 Sep 2024 was 131,793,088, a 182% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

MARIZYME, INC. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 131,793,088 +85,126,328 +182% 30 Sep 2024 10-Q 05 Mar 2025 2024 Q3
Q2 2024 131,793,088 +86,426,328 +191% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 131,793,088 +91,024,897 +223% 31 Mar 2024 10-Q 28 May 2024 2024 Q1
Q4 2023 131,793,088 +91,264,897 +225% 31 Dec 2023 10-Q 05 Mar 2025 2024 Q3
Q3 2023 46,666,760 +5,838,572 +14% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 45,366,760 +4,538,572 +11% 30 Jun 2023 10-Q 18 Aug 2023 2023 Q2
Q1 2023 40,768,191 -59,997 -0.15% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 40,528,191 0 0% 31 Dec 2022 10-K/A 06 Feb 2025 2023 FY
Q3 2022 40,828,188 +4,900,000 +14% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 40,828,188 +4,900,000 +14% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 40,828,188 +4,900,000 +14% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 40,528,191 +4,600,003 +13% 31 Dec 2021 10-K 24 Mar 2023 2022 FY
Q3 2021 35,928,188 -15,960,000 -31% 30 Sep 2021 10-Q 22 Nov 2021 2021 Q3
Q2 2021 35,928,188 +15,744,249 +78% 30 Jun 2021 10-Q/A 22 Nov 2021 2021 Q2
Q1 2021 35,928,188 +15,944,249 +80% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 35,928,188 +16,069,249 +81% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 51,888,188 +32,029,249 +161% 30 Sep 2020 10-Q/A 24 Nov 2020 2020 Q3
Q2 2020 20,183,939 +325,000 +1.6% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 19,983,939 +243,637 +1.2% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 19,858,939 +118,637 +0.6% 31 Dec 2019 10-K 15 Apr 2021 2020 FY
Q3 2019 19,858,939 +277,865 +1.4% 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 19,858,939 30 Jun 2019 10-Q 03 Jul 2019 2019 Q2
Q1 2019 19,740,302 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 19,740,302 +18,639,228 +1693% 31 Dec 2018 10-K 15 Apr 2020 2019 FY
Q3 2018 19,581,074 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q4 2017 1,101,074 -30,828,217 -97% 31 Dec 2017 10-K 05 Mar 2019 2018 FY
Q4 2016 31,929,291 0 0% 31 Dec 2016 10-K/A 28 Nov 2018 2017 FY
Q4 2015 31,929,291 0 0% 31 Dec 2015 10-K/A 28 Nov 2018 2017 FY
Q4 2014 31,929,291 +716,677 +2.3% 31 Dec 2014 10-K/A 28 Nov 2018 2017 FY
Q4 2013 31,212,614 +1,750,950 +5.9% 31 Dec 2013 10-K/A 28 Nov 2018 2017 FY
Q3 2013 30,837,624 +1,405,960 +4.8% 30 Sep 2013 10-Q/A 15 May 2014 2013 Q3
Q2 2013 30,812,624 +1,380,960 +4.7% 30 Jun 2013 10-Q/A 22 Aug 2013 2013 Q2
Q1 2013 30,812,624 +2,600,960 +9.2% 31 Mar 2013 10-Q/A 15 Aug 2013 2013 Q1
Q4 2012 29,461,664 +2,155,000 +7.9% 31 Dec 2012 10-K/A 28 Nov 2018 2017 FY
Q3 2012 29,431,664 +4,757,874 +19% 30 Sep 2012 10-Q/A 17 Dec 2012 2012 Q3
Q2 2012 29,431,664 +5,637,874 +24% 30 Jun 2012 10-Q/A 13 Sep 2012 2012 Q1
Q1 2012 28,211,664 +5,667,664 +25% 31 Mar 2012 10-Q/A 13 Sep 2012 2012 Q1
Q4 2011 27,306,664 0 0% 31 Dec 2011 10-K/A 08 May 2014 2012 FY
Q3 2011 24,673,790 30 Sep 2011 10-Q/A 19 Jul 2013 2011 Q3
Q2 2011 23,793,790 30 Jun 2011 10-Q/A 18 Jul 2013 2011 Q2
Q1 2011 22,544,000 31 Mar 2011 10-K 16 Jul 2012 2011 FY
Q4 2010 27,306,664 31 Dec 2010 10-K/A 31 Mar 2014 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.